Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > calling and asking
View:
Post by DJDawg on Mar 01, 2022 4:21pm

calling and asking

Just a thought. Didn't someone call TLT in November to clarify the plan with the Quarterly? Got the info that it would be end November. People have been talking about the upcoming one which is great. But did someone call? I'm hard of hearing so I'm happy to email (phones don't go well for me) but thought I would check first.
Comment by 99942Apophis on Mar 01, 2022 4:53pm
Hi DJDawg they can't give out timing of news releases or pertinent information, future information timing or news releases would violate security commission rules. That is why we as shareholders take guesses at when it will occur. We all think it will be very good we just want to see the official release.
Comment by skys1 on Mar 01, 2022 7:24pm
Not so Apophis, I was the one who called last time to get the date of the Quarterly release. I reported, "it will be released in conjunction with the financial report" at the end of the month, if you'l remember.
Comment by 99942Apophis on Mar 01, 2022 9:02pm
skys1 wrote not so Apophis, I was the one who called last time to get the date of the Quarterly release. I reported, "it will be released in conjunction with the financial report" at the end of the month, if you'l remember. Yes skys1 perhaps that is a grey area, maybe you could give them a call tomorrow, thanks.
Comment by floatinketucky on Mar 01, 2022 6:12pm
I think they are looking at rulings for PIV PH2 patients and have not conclued the full decision.  So we wait till the numbers are finalized by review..  JMO...
Comment by floatinketucky on Mar 01, 2022 9:37pm
I think the final piece of the puzzle is about to go together. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250